challenges
Drug discovery is slow, expensive, and constrained by poor datasets and models, limited chemical space and inefficient synthesis pathways—leading to high failure rates and delayed treatments.
solution
Pending AI integrates quantum-accurate AI binding models with the world’s largest proprietary database of >1T molecules and a novel retrosynthesis engine delivering lab-ready synthetic steps for rapid execution.
You might also like
For founders
Building for the systems that matter? Pitch us.
We back founders turning breakthrough science into category-defining companies.
For investors
Invest with Main Sequence
Access Australia's deep tech frontier alongside us.








